Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure†

2010 ◽  
Vol 53 (1) ◽  
pp. 201-207 ◽  
Author(s):  
Serena Scapecchi ◽  
Marta Nesi ◽  
Rosanna Matucci ◽  
Cristina Bellucci ◽  
Michela Buccioni ◽  
...  
Keyword(s):  
Functional Activity ◽  
Muscarinic Antagonists ◽  
Affinity Profile

Synthesis, Affinity Profile, and Functional Activity of Muscarinic Antagonists with a 1-Methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine Structure†

2007 ◽  
Vol 50 (6) ◽  
pp. 1409-1413 ◽  
Author(s):  
Silvia Dei ◽  
Cristina Bellucci ◽  
Michela Buccioni ◽  
Marta Ferraroni ◽  
Luca Guandalini ◽  
...  
Keyword(s):  
Functional Activity ◽  
Muscarinic Antagonists ◽  
Affinity Profile

Binding affinity profile of selective muscarinic antagonists in guinea-pig gallbladder

Life Sciences ◽  
1995 ◽  
Vol 56 (11-12) ◽  
pp. 1039 ◽  
Author(s):  
Ş. Oktay ◽  
E. İskender ◽  
F. Onat ◽  
B.Ç. Yeǧen ◽  
N.B. Ulusoy
Keyword(s):  
Guinea Pig ◽  
Binding Affinity ◽  
Muscarinic Antagonists ◽  
Affinity Profile

Molecular modulation of muscarinic antagonists. Synthesis and affinity profile of 2,2-diphenyl-2-ethylthio-acetic acid esters designed to probe the binding site cavity

Il Farmaco ◽  
2004 ◽  
Vol 59 (12) ◽  
pp. 971-980 ◽  
Author(s):  
Serena Scapecchi ◽  
Elisabetta Martini ◽  
Cristina Bellucci ◽  
Michela Buccioni ◽  
Silvia Dei ◽  
...  
Keyword(s):  
Acetic Acid ◽  
Binding Site ◽  
Muscarinic Antagonists ◽  
Molecular Modulation ◽  
Acetic Acid Esters ◽  
Acid Esters ◽  
Affinity Profile

Representing utility and deploying the body

2020 ◽  
Vol 43 ◽  
Author(s):  
David Spurrett
Keyword(s):  
Functional Activity ◽  
Degrees Of Freedom ◽  
The Body ◽  
Target Article ◽  
Processing Demands ◽  
The Many

Abstract Comprehensive accounts of resource-rational attempts to maximise utility shouldn't ignore the demands of constructing utility representations. This can be onerous when, as in humans, there are many rewarding modalities. Another thing best not ignored is the processing demands of making functional activity out of the many degrees of freedom of a body. The target article is almost silent on both.

Plasma Derived von Willebrand Factor Preparations: Collagen Binding and Ristocetin Cofactor Activities

1997 ◽  
Vol 78 (02) ◽  
pp. 930-933 ◽  
Author(s):  
Ping Chang ◽  
D L Aronson
Keyword(s):  
Von Willebrand Factor ◽  
Functional Activity ◽  
Binding Activity ◽  
Collagen Binding ◽  
Binding Function ◽  
Cofactor Activity ◽  
Von Willebrand ◽  
Willebrand Factor ◽  
Ristocetin Cofactor ◽  
Ristocetin Cofactor Activity

SummaryFive plasma preparations (11 lots) used in the treatment of von Willebrand’s disease (vWD) were evaluated. The collagen binding function of von Willebrand factor (vWF) containing preparations was compared with the ristocetin cofactor activity and the vWF antigen. Some preparations have higher ratio of functional activity (ristocetin cofactor and collagen binding) relative to the antigen than is found in normal plasma. The ristocetin cofactor activity and the collagen binding activity are tightly correlated (r = .95). Ultracentrifugal (UCF) analysis was used to compare the size distribution of vWf antigen, ristocetin cofactor and collagen binding activity. The sedimentation of all of the vWF parameters in the plasma products was slower than in plasma. In plasma products the ristocetin cofactor activity sediments the most rapidly, the collagen binding activity is slower and the antigen the slowest. The collagen/antigen ratio decreases with decreasing vWF size. Assignment of potency to vWF containing preparations utilizing the collagen binding activity may be more precise and as accurate as with the traditional ristocetin cofactor assay.

Sign in / Sign up

Export Citation Format

Share Document